Mr. Taras Manolov
P.O.Box 130
TOV “PETOSEVIC”
Kyiv
01042
Ukraine
Taras handles patent prosecution, enforcement and litigation in Ukraine and other countries in the region, and advises clients on all aspects of patent protection. He has extensive experience in preparing, filing and prosecuting patent applications in the fields of medicine, pharmacology, biotechnology and chemistry. Taras also handles the protection of plant breeder’s rights and the admission of plant varieties to national lists.
Taras represents clients from a variety of industries. Notably, he recently provided advice and assistance regarding patent filing and prosecution in Armenia to two well-known consumer goods companies. He also advised on and coordinated plant variety application filing in multiple countries for a multinational plant breeding company.
Prior to joining PETOŠEVIĆ in 2020, Taras worked as a patent expert at Gorodissky and Partners in Kyiv for nine years. Previously, his career in research and academia focused on bacterial pathogenicity, environmental biotechnology and bacterial biosensors, and spanned 13 years. During this time, Taras worked as a researcher at the Max Planck Institute for Infection Biology in Berlin and at Lund University in Sweden, and as an engineer at the National Academy of Sciences of Ukraine. Taras also worked as a patent liaison for Ukrainian pharmaceutical company Yuria-Pharm.
Intellectual Property, 2013–2015; Intellectual Property Institute, Kyiv, Ukraine
PhD, Medical Science, 2005–2008; Lunds universitet, Sweden
MSc, biology/microbiology, 1993–1998; Taras Shevchenko National University, Kyiv, Ukraine
Experience & Qualifications
- Biochemistry and pharmacology
- Biology; agricultural science
- Biotechnology; plant technology
- Chemistry
- Medical and veterinary methods and products
- IP counselling
- Patent drafting
- Patent prosecution
Roles in FICPI
-
CET 5 Biotechnology and Pharmaceuticals
CET Group 5 is dedicated to following, reporting and providing substantive comments and opinions on emerging issues relating to the patenting and regulatory affairs in the Biotechnology and Pharmaceutical fields.
In addition, CET 5 is closely following developments related to genetic resources and developing requirements for notice on their country of origin. Prominent issues CET 5 addresses regarding patenting in these technological fields include subject matter eligibility, and in particular, the patentability of chemical/biological inventions developed using machines, computer implementation and/or artificial intelligence. CET 5 supports FICPI in its mission to be an international leader promoting patent protection in the biotechnology and pharmaceutical arts.
- Member
- English
- Swedish
- Ukrainian
- Russian